These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1181974)

  • 1. Mass screenings for cervical cancer in Finland 1963-71. Organization, extent, and epidemiological implications.
    Hakama M; Joutsenlahti U; Virtanen A; Räsänen-Virtanen U
    Ann Clin Res; 1975 Apr; 7(2):101-11. PubMed ID: 1181974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of cervical cancer subsequent to a positive screening cytology: follow-up study in Finland.
    Viikki M; Pukkala E; Hakama M
    Acta Obstet Gynecol Scand; 2000 Jul; 79(7):576-9. PubMed ID: 10929958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cervical cancer screening in Scandinavia.
    Day NE
    Obstet Gynecol; 1984 May; 63(5):714-8. PubMed ID: 6717876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of cytologic mass screening in the Federal Republic of Germany.
    Soost HJ; Bockmühl B; Zock H
    Acta Cytol; 1982; 26(4):445-52. PubMed ID: 6957096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of cervical neoplasia.
    La Vecchia C
    Biomed Pharmacother; 1985; 39(8):426-33. PubMed ID: 3841750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass screening for cervical carcinoma in Finland. Organization and effect on morbidity and mortality.
    Timonen S; Nieminen U; Kauraniemi T
    Ann Chir Gynaecol Fenn; 1974; 63(2):104-12. PubMed ID: 4853102
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cervical cancer after 10 years of nationally coordinated screening].
    Haldorsen T; Skare GB; Steen R; Thoresen SO
    Tidsskr Nor Laegeforen; 2008 Mar; 128(6):682-5. PubMed ID: 18337847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A screening programme for cervical cancer that worked.
    Hakama M; Louhivuori K
    Cancer Surv; 1988; 7(3):403-16. PubMed ID: 3242792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri.
    Nieminen P; Kallio M; Hakama M
    Obstet Gynecol; 1995 Jun; 85(6):1017-21. PubMed ID: 7770247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995.
    Sigurdsson K
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):478-85. PubMed ID: 10376856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a mass screening program on the risk of cervical cancer.
    Louhivuori K
    Cancer Detect Prev; 1991; 15(6):471-5. PubMed ID: 1782637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer screening in Serbia.
    Kesić V; Jovićević-Bekić A; Vujnović M
    Coll Antropol; 2007 Apr; 31 Suppl 2():31-6. PubMed ID: 17598502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.
    van der Aa MA; Pukkala E; Coebergh JW; Anttila A; Siesling S
    Int J Cancer; 2008 Apr; 122(8):1854-8. PubMed ID: 18067129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience of a continuing mass screening programme. Screening and re-screening for cervical carcinoma in Turku.
    Grönroos M; Tyrkkö J; Järvi O; Rauramo L
    Ann Chir Gynaecol Fenn; 1974; 63(6):470-8. PubMed ID: 4441027
    [No Abstract]   [Full Text] [Related]  

  • 15. [Progress in the early detection of cervix cancer from the viewpoint of the Saarland cancer register].
    Brenner H; Wiebelt H; Ziegler H
    Geburtshilfe Frauenheilkd; 1990 Apr; 50(4):304-9. PubMed ID: 2358181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of screening on the incidence of cervical cancer in Alberta.
    Starreveld AA; Hill GB; Brown LB; Koch M
    Can Med Assoc J; 1981 Nov; 125(10):1105-9. PubMed ID: 7326641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population.
    Syrjänen K; Hakama M; Saarikoski S; Väyrynen M; Yliskoski M; Syrjänen S; Kataja V; Castrén O
    Sex Transm Dis; 1990; 17(1):15-9. PubMed ID: 2154865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of cervical cancer in Taiwan.
    Wang PD; Lin RS
    Gynecol Oncol; 1996 Sep; 62(3):344-52. PubMed ID: 8812531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement in protection against adenocarcinoma of the cervix resulting from participation in cervical screening.
    Mitchell H; Hocking J; Saville M
    Cancer; 2003 Dec; 99(6):336-41. PubMed ID: 14681940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.